![]() This program is not financed by or connected in any manner with any governmental agency or veteran's or other organization. ![]() Charles is survived by his loving wife Deborah Williams, children Adam Williams, Aaron Williams, Joshua Williams, and wife Jahne Williams, Jason Williams, Aliyah Holloway and Tenisha Worley. Past results do not guarantee a similar outcome.Wake: Saturday, May 18, from 5:30-6:30 p.m. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.Īttorney Advertising. To be notified if a class action against Charles Rivers Laboratories, International, Inc. Since our inception, we have obtained over $1 billion for shareholders. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. ![]() Shareholders pay no fees or expenses.Ībout Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions Robbins LLP does. For more information, click here.Īll representation is on a contingency fee basis. If you choose to take no action, you can remain an absent class member. You do not have to participate in the case to be eligible for a recovery. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Shareholders who want to act as lead plaintiff for the class must file their papers by July 18, 2023. What Now: Similarly situated shareholders may be eligible to participate in the class action against Charles Rivers Laboratories, International, Inc. Department of Justice and, (3) Charles River would be forced to suspend shipments of primates from Cambodia. The complaint alleges that defendants failed to disclose to investors that: (1) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research (2) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the U.S. The article specifically called out Charles River and other research organizations as providing primates to drug companies and academic and government scientists, which they obtain from multiple sources, including international suppliers. On March 1, 2023, The Washington Post published an article linking the investigation to a November 2022 indictment of a monkey-smuggling ring. On this news, Charles River’s stock price fell $24.51, or 10%, to close at $219.09 per share on February 22, 2023, on unusually heavy trading volume. The Company noted that it was voluntarily suspending shipments of primates from Cambodia, which would negatively impact its earnings for the year and would reduce revenue growth by 200 basis points to 400 basis points. Fish and Wildlife Service into the supply chain and illegal importation of non-human primates for research. Department of Justice relating to an ongoing investigation in conjunction with the U.S. (CRL) Misled Investors Regarding its Importation of Non-Human Primates for ResearchĪccording to the complaint, on February 22, 2023, Charles River revealed that it had received a subpoena from the U.S. What is this Case About: Charles River Laboratories International, Inc. Charles River is a full-service, non-clinical global drug development partner with a mission to create healthier lives.įor more information, submit a form, email Aaron Dumas, Jr., or give us a call (800) 350-6003. ![]() (NYSE: CRL) for wrongdoing between and February 21, 2023. SAN DIEGO, J(GLOBE NEWSWIRE) - Robbins LLP reminds investors that a shareholder filed a class action against Charles River Laboratories International, Inc. ![]()
0 Comments
Leave a Reply. |